Qube Research & Technologies Ltd - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$393,990
+254.9%
165,542
+409.9%
0.00%0.0%
Q2 2022$111,000
+5.7%
32,468
+119.5%
0.00%0.0%
Q1 2022$105,000
-91.3%
14,789
-89.8%
0.00%
-88.9%
Q4 2021$1,205,000144,7170.01%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 12,682,876$125,560,00040.85%
ARK Investment Management 492,064$4,871,0001.77%
Artal Group S.A. 700,000$6,930,0000.15%
Portolan Capital Management 111,054$1,099,0000.15%
Rock Springs Capital Management LP 220,000$2,178,0000.15%
CQS Cayman LP 162,000$1,604,0000.13%
Opus Point Partners Management, LLC 14,000$139,0000.11%
HAMILTON LANE ADVISORS LLC 14,883$147,0000.10%
Geduld E E 15,000$149,0000.08%
Virtus ETF Advisers LLC 28,148$279,0000.08%
View complete list of SERES THERAPEUTICS INC shareholders